TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Market Capitalization	13,127	16,720	23,485	20,746	17,843	17,813	Upgrade
Market Cap Growth	-45.37%	-28.80%	13.20%	16.27%	0.17%	-16.02%	Upgrade
Enterprise Value	11,852	15,456	21,842	20,859	17,860	17,487	Upgrade
Last Close Price	48.05	61.20	86.00	80.83	69.69	69.59	Upgrade
Forward PE	-	-	-	282.76	-	-	Upgrade
PS Ratio	21.47	27.35	38.49	42.19	31.69	43.09	Upgrade
PB Ratio	3.40	4.33	5.84	8.09	6.57	6.06	Upgrade
P/TBV Ratio	3.84	4.89	6.74	10.69	8.96	8.40	Upgrade
P/FCF Ratio	77.92	99.24	-	-	-	-	Upgrade
P/OCF Ratio	68.68	87.47	-	-	-	-	Upgrade
EV/Sales Ratio	19.39	25.28	35.80	42.42	31.72	42.30	Upgrade
EV/FCF Ratio	70.35	91.74	-	-	-	-	Upgrade
Debt / Equity Ratio	0.13	0.13	0.13	0.29	0.28	0.19	Upgrade
Debt / FCF Ratio	2.93	2.93	-	-	-	-	Upgrade
Net Debt / Equity Ratio	-0.33	-0.33	-0.28	0.04	0.05	-0.13	Upgrade
Net Debt / EBITDA Ratio	27.42	27.42	10.81	-5.89	-2.92	1.16	Upgrade
Net Debt / FCF Ratio	-7.57	-7.57	2.91	-3.29	-0.20	1.77	Upgrade
Asset Turnover	0.13	0.13	0.14	0.12	0.13	0.08	Upgrade
Inventory Turnover	0.24	0.24	0.28	0.20	0.27	0.27	Upgrade
Quick Ratio	7.48	7.48	13.26	2.31	2.32	5.12	Upgrade
Current Ratio	13.11	13.11	25.18	5.96	6.56	10.37	Upgrade
Return on Equity (ROE)	-4.26%	-4.26%	-6.13%	-7.38%	-9.52%	-14.82%	Upgrade
Return on Assets (ROA)	-2.48%	-2.48%	-3.55%	-2.60%	-2.75%	-6.20%	Upgrade
Return on Capital Employed (ROCE)	-4.30%	-4.30%	-5.20%	-4.70%	-5.10%	-11.10%	Upgrade
Earnings Yield	-1.28%	-1.00%	-0.86%	-0.94%	-1.51%	-2.64%	Upgrade
FCF Yield	1.28%	1.01%	-1.65%	-0.15%	-3.41%	-1.24%	Upgrade
Buyback Yield / Dilution	-1.85%	-1.85%	-6.08%	-0.18%	-0.04%	-0.03%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.